Cerebrospinal fluid monoamine catabolites in drug-induced extrapyramidal disorders.
D000588:Amines / Q000096:biosynthesis; D001921:Brain / Q000378:metabolism; D002746:Chlorpromazine / Q000009:adverse effects; D005116:Extrapyramidal Tracts; D005260:Female; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid*; D009069:Movement Disorders / Q000134:cerebrospinal fluid* / Q000139:chemically induced*; D010300:Parkinson Disease / Q000134:cerebrospinal fluid*; D010648:Phenylacetates / Q000134:cerebrospinal fluid*; D012559:Schizophrenia / Q000134:cerebrospinal fluid*; D013881:Thioridazine / Q000009:adverse effects; D014268:Trifluoperazine / Q000009:adverse effects
D000588:Amines; D010648:Phenylacetates; D014268:Trifluoperazine; D006897:Hydroxyindoleacetic Acid; D013881:Thioridazine; D002746:Chlorpromazine